Thermo Fisher Scientific Inc.TMONYSE
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank64
3Y CAGR-2.3%
5Y CAGR+3.2%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-2.3%/yr
vs +4.5%/yr prior
5Y CAGR
+3.2%/yr
Recent deceleration
Acceleration
-6.8pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20250.76+15.7%
20240.66-15.2%
20230.78-5.0%
20220.82-7.9%
20210.89+36.3%
20200.65+4.9%
20190.62-9.5%
20180.69-16.7%
20170.83+7.1%
20160.77-